New US Patent Awarded

Phoenicia Scientists were awarded a new US patent (8,759,378, Issued June 24, 2014: “Methods for Treating Blood Disorders”), on newly-discovered small molecules which regulate fetal hemoglobin production for  treatment of β-thalassemiaand sickle cell disease.